Nantong Jinghua Pharmaceutical Co Ltd Strategic Asset Allocation Index
Nantong Jinghua Pharmaceutical Co Ltd strategic asset allocation index. Nantong Jinghua Pharmaceutical Co Ltd (002349) has a Strategic Asset Allocation Index of 24.3% as of September 2023. Strategic assets (PP&E of CN¥669.19 Million plus long-term investments of CN¥-) total CN¥669.19 Million, measured against net assets of CN¥2.75 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Nantong Jinghua Pharmaceutical Co Ltd's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Nantong Jinghua Pharmaceutical Co Ltd (2006–2022)
Strategic asset allocation index of Nantong Jinghua Pharmaceutical Co Ltd from 2006 to 2022. This chart shows how Nantong Jinghua Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 17 annual periods from 2006 to 2022. As of September 2023, the index stands at 24.3%, representing strategic assets of CN¥669.19 Million against net assets of CN¥2.75 Billion CNY. Check Nantong Jinghua Pharmaceutical Co Ltd (002349) tangible net worth to evaluate the tangible quality of the company's equity base.
Nantong Jinghua Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2006–2022)
Nantong Jinghua Pharmaceutical Co Ltd strategic asset allocation index by year from 2006 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Nantong Jinghua Pharmaceutical Co Ltd from 2006 to 2022, covering 17 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 002349 market cap overview.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 27.0% | CN¥708.42 Million | CN¥708.42 Million | CN¥- | CN¥2.62 Billion | ▼ -18.5 pp |
| 2021 | 45.5% | CN¥1.17 Billion | CN¥1.17 Billion | CN¥- | CN¥2.57 Billion | ▼ -3.2 pp |
| 2020 | 48.7% | CN¥1.21 Billion | CN¥1.21 Billion | CN¥- | CN¥2.49 Billion | ▼ -10.6 pp |
| 2019 | 59.3% | CN¥1.27 Billion | CN¥1.27 Billion | CN¥- | CN¥2.15 Billion | ▲ +9.6 pp |
| 2018 | 49.7% | CN¥1.34 Billion | CN¥1.22 Billion | CN¥117.27 Million | CN¥2.69 Billion | ▲ +5.9 pp |
| 2017 | 43.8% | CN¥1.16 Billion | CN¥1.04 Billion | CN¥115.97 Million | CN¥2.65 Billion | ▲ +7.3 pp |
| 2016 | 36.5% | CN¥840.83 Million | CN¥713.14 Million | CN¥127.69 Million | CN¥2.30 Billion | ▲ +5.3 pp |
| 2015 | 31.2% | CN¥697.90 Million | CN¥551.86 Million | CN¥146.04 Million | CN¥2.23 Billion | ▼ 0.0 pp |
| 2014 | 31.2% | CN¥479.53 Million | CN¥479.53 Million | CN¥- | CN¥1.53 Billion | ▼ -36.3 pp |
| 2013 | 67.5% | CN¥500.80 Million | CN¥500.80 Million | CN¥- | CN¥741.83 Million | ▲ +17.3 pp |
| 2012 | 50.2% | CN¥358.86 Million | CN¥358.86 Million | CN¥- | CN¥714.87 Million | ▲ +24.0 pp |
| 2011 | 26.2% | CN¥166.59 Million | CN¥166.59 Million | CN¥- | CN¥636.30 Million | ▲ +8.7 pp |
| 2010 | 17.5% | CN¥95.24 Million | CN¥95.24 Million | CN¥- | CN¥544.45 Million | ▼ -50.9 pp |
| 2009 | 68.4% | CN¥93.75 Million | CN¥93.75 Million | CN¥- | CN¥137.11 Million | ▼ -5.5 pp |
| 2008 | 73.9% | CN¥87.70 Million | CN¥87.70 Million | CN¥- | CN¥118.66 Million | ▼ -30.5 pp |
| 2007 | 104.5% | CN¥95.95 Million | CN¥95.95 Million | CN¥- | CN¥91.86 Million | ▼ -44.9 pp |
| 2006 | 149.4% | CN¥104.57 Million | CN¥104.57 Million | CN¥- | CN¥70.00 Million | — |